(PharmaNewsWire.Com, May 05, 2017 ) According to the report Europe Cancer Vaccines Market, published by Market Data Forecast, the Europe market is projected to reach USD 1.58 billion by 2021, at a CAGR of 16.29% from 2016 to 2021
Mostly, therapeutic vaccines are a form of immunotherapy. Therapeutic vaccines which are intended raise the bodys natural immune to response against cancer cells to treat an existing cancer. The numerous immune effector mechanisms mobilized by therapeutic vaccination precisely attack and destroy cancer cells and leave normal cells. Thus, therapeutic cancer vaccines, in general, may be used to inhibit further growth of advanced cancers, relapsed tumours that are refractory to conventional therapies, such as radiation therapy, surgery, and chemotherapy.
Europe cancer vaccines market is primarily driven by presence of strong late-stage pipeline Vaccines, increasing public awareness of vaccines, rising number of people with cancer, and smoking and excessive alcoholic intake, vendors' patient-assistance programs are the major factors driving the growth of the market. Vaccines costs, stringent regulations for the approval are the factors restraining the growth of the market.
The Cancer Vaccines Market is segmented as following:
Based on Treatment Type: Prophylactic Therapeutic Y-o-Y Growth Analysis, By Cancer Type Market Attractiveness Analysis, By Cancer type Market Share Analysis, By Cancer Type
Based on Cancer Type: Introduction Prostate Cancer Cervical Cancer Colorectal Cancer Throat Cancer Others Y-o-Y Growth Analysis, By Cancer Type Market Attractiveness Analysis, By Cancer type Market Share Analysis, By Cancer Type
Based on Vaccine Type: Introduction Tumour cell Vaccines Protein or Peptide Vaccines Genetic Vaccines Dendritic cell Vaccines other Vaccines Y-o-Y Growth Analysis, By Vaccine Type Market Attractiveness Analysis, By Vaccine Type Market Share Analysis, By Vaccine Type
Based on End Users: Introduction Cancer Treatment Centers Research Institutes Y-o-Y Growth Analysis, By End User Market Attractiveness Analysis, By End User Market Share Analysis, By End User
The major companies operating in the Europe Cancer Vaccines Market are GlaxoSmithKline, Dendreon and Merck. Other companies whose products are in pipeline stage are Agenus, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Galena Biopharma, Heat Biologics, ISA Pharmaceuticals, Inovio Pharmaceuticals, Juvaris Biotherapeutics, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prsima BioMed, Sotio, Transgene, Immatics, ImmunoCellular Therapeutics, GlobeImmune, Gradalis, Biothera, Celldex Therapeutics, Genexine, Aduro Biotech, Advantagene, Advaxis, Altor BioScience, CureVac, Ubivac, Vaccinogen, Vaxon Biotech
The Cancer Vaccines Market study offers the following deliverables:
Europe, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of the effect of exogenous and endogenous factors that affect the Europe market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
Study the microenvironment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development
A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Check out other related studies in the Therapeutics Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
